全球動物健康的聯盟條件與契約 (2017～2024年)

本報告提供了有關公司為何以及在什麼條件下進行動物健康合作的詳細資訊和分析。這些協議往往是多方面的，從聯合研發開始，一直到成果的商業化。

本報告提供了自 2017 年以來生命科學領域宣布的 269 份動物健康合約的詳細資訊。

本報告對動物健康方面的合約趨勢、主要公司、主要合約金額和合約財務進行了全面回顧，並研究了各公司如何、為何以及在什麼條件下簽訂動物健康方面的合作合約。做什麼。

本報告從財務角度評估了動物健康領域交易的期限和價值，並包括交易總額、預付款、里程碑和特許權使用費率等信息，以幫助讀者了解交易的財務價值。比較。

本報告的中間部分考察了動物健康合作領域的領先交易者。報告了動物保健領域關鍵交易的交易價值和最活躍的交易撮合者，讓讀者了解哪些公司在這個充滿活力的交易市場中取得了成功。

對於動物保健領域的實際交易，我們提供了交易方披露的在線交易記錄，按公司名稱（A-Z）、發展階段、交易類型、具體治療靶點和技術類型列於報告末尾。目錄格式。報告中的每個交易記錄都透過網路連結連結到交易的線上版本。

此外，如果有的話，我們會記錄公司及其附屬公司向美國證券交易委員會提交的合約文件。雖然許多公司希望了解其付款條件的詳細信息，但在付款方式方面，細節才是王道。

本報告還包括一些圖表，顯示自 2017 年以來動物健康合作夥伴關係和交易的趨勢和活動。

總而言之，本報告提供了潛在交易者需要了解的有關動物健康領域研發和商業化合作夥伴關係的所有資訊。

主要的優點

該報告為讀者提供了以下主要優點：

• 有關動物健康合約趨勢的詳細資訊（自 2017 年以來）
• 取得交易金額、預付款、里程碑和版稅率數據
• 主要生物製藥公司在動物健康方面簽署的實際協議：獲取詳細信息
• 確定動物健康領域最活躍的交易撮合者（自 2017 年起）
• 公司過去同意的主要合約條件的說明
• 進行盡職調查：評估向合作夥伴公司提出的合約條款的適當性

調查範圍

• 本報告旨在讓讀者深入了解和了解全球領先的動物保健公司所進行的交易的趨勢和結構。

動物健康領域的合作條件和合約詳細資料：

• 生物製藥產業動物保健交易趨勢（2017年以來）
• 取得交易金額、預付款、里程碑和版稅率數據
• 取得動物健康方面的合約文件
• 動物保健領域主要總量及需求量交易金額（2017年至今）
• 動物保健領域最活躍的交易撮合者（自 2017 年起）

此報告列出了可用合約的以下資訊：

• 公司名稱（A-Z）
• 總交易金額
• 合約簽訂時的開發階段
• 合約組成部分的類型
• 具體治療標靶
• 技術類型
• 每筆交易的標題都透過網路連結連結到交易記錄的線上版本以及合約文件（如果有），從而可以輕鬆按需存取每份合約文件。

透過分析實際合同，可以評估：

• 授予或選擇的具體權利是什麼？
• 合約實際上賦予了合作夥伴公司什麼？
• 授予哪些類型的專有權？
• 合約的付款結構是怎樣的？
• 如何審核銷售和付款？
• 條款和條件是什麼？
• 合約的主要條款是如何定義的？
• 智慧財產權的處理和所有權如何？
• 誰負責商業化？
• 誰負責開發、供應和製造？
• 如何管理保密和發布？
• 如何解決爭議？
• 什麼情況下可以取消合約？
• 如果所有者發生變化會怎樣？
• 已就何種類型的分授權或分包條款達成協議？
• 公司主張哪些樣板條款？
• 根據合作夥伴關係或交易的類型，哪些樣板條款看起來有所不同？
• 公司對契約法主張哪一個管轄權？

目錄

摘要整理

第1章 簡介

第2章 動物健康的交易趨勢

• 簡介
• 動物健康的長期性的聯盟趨勢
• 在動物健康中最活躍的交易商
• 動物健康的聯盟趨勢:各交易類型
• 動物健康的聯盟趨勢:各治療領域
• 動物健康的聯盟趨勢:各技術種類
• 動物健康的聯盟條件
  • 動物健康的聯盟的交易總額
  • 動物健康的交易的預付款金
  • 動物健康的交易的里程金
  • 動物健康的特許權率

第3章 動物健康的主要交易

• 簡介
• 動物健康的主要交易:交易額

第4章 動物健康的最活躍的交易商

• 簡介
• 動物健康的最活躍的交易商
• 動物健康的最活躍的聯盟企業:簡介

第5章 動物健康的契約交易一覽

• 簡介
• 動物健康的契約交易一覽

第6章 動物健康的交易趨勢:各技術種類

附錄

Welcome to the Global Animal Health Partnering Terms and Agreements 2017 to 2024 report.

The report provides a detailed understanding and analysis of how and why companies enter animal health partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of 269 animal health agreements announced in the life sciences since 2017.

The report takes the reader through a comprehensive review animal health deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering animal health partnering deals.

The report presents financial deal term values for animal health deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the animal health partnering field; both the leading deal values and most active animal health dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

Online deal records of actual animal health deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of animal health dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in animal health dealmaking since 2017, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading animal health deals since 2017. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in animal health dealmaking with a brief summary followed by a comprehensive listing of animal health deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of animal health partnering deals signed and announced since Jan 2017, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of animal health partnering deals signed and announced since Jan 2017. The chapter is organized by specific animal health technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by animal health partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in animal health partnering and dealmaking since 2017.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of animal health technologies and products.

Key benefits

Global Animal Health Partnering Terms and Agreements 2017-2024 provides the reader with the following key benefits:

• In-depth understanding of animal health deal trends since 2017
• Access to headline, upfront, milestone and royalty data
• Detailed access to actual animal health contracts entered into by leading biopharma companies
• Identify most active animal health dealmakers since 2017
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

• Global Animal Health Partnering Terms and Agreements 2017 to 2024 is intended to provide the reader with an in-depth understanding and access to animal health trends and structure of deals entered into by leading companies worldwide.

Animal Health Partnering Terms and Agreements includes:

• Trends in animal health dealmaking in the biopharma industry since 2017
• Access to headline, upfront, milestone and royalty data
• Access to animal health contract documents
• Leading animal health deals by value since 2017
• Most active animal health dealmakers since 2017

In Global Animal Health Partnering Terms and Agreements 2017 to 2024, the available deals are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
• Technology type
• Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Analyzing actual contract agreements allows assessment of the following:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in animal health dealmaking

• 2.1. Introduction
• 2.2. Animal health partnering over the years
• 2.3. Most active animal health dealmakers
• 2.4. Animal health partnering by deal type
• 2.5. Animal health partnering by therapy area
• 2.6. Animal health partnering by technology type
• 2.7. Deal terms for animal health partnering
  • 2.7.1 Animal health partnering headline values
  • 2.7.2 Animal health deal upfront payments
  • 2.7.3 Animal health deal milestone payments
  • 2.7.4 Animal health royalty rates

Chapter 3 - Leading animal health deals

• 3.1. Introduction
• 3.2. Top animal health deals by value

Chapter 4 - Most active animal health dealmakers

• 4.1. Introduction
• 4.2. Most active animal health dealmakers
• 4.3. Most active animal health partnering company profiles

Chapter 5 - Animal health contracts dealmaking directory

• 5.1. Introduction
• 5.2. Animal health contracts dealmaking directory

Chapter 6 - Animal health dealmaking by technology type

Appendices

• Appendix 1 - Animal health deals by company A-Z
• Appendix 2 - Animal health deals by stage of development
• Appendix 3 - Animal health deals by deal type
• Appendix 4 - Animal health deals by therapy area
• Appendix 5 - Deal type definitions
• Appendix 6 - Further reading
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Animal health partnering since 2017
• Figure 2: Active animal health dealmaking activity- 2017 to 2024
• Figure 3: Animal health partnering by deal type since 2017
• Figure 4: Animal health partnering by disease type since 2017
• Figure 5: Animal health partnering by technology type since 2017
• Figure 6: Animal health deals with a headline value
• Figure 7: Animal health deals with an upfront value
• Figure 8: Animal health deals with a milestone value
• Figure 9: Animal health deals with a royalty rate value
• Figure 10: Top animal health deals by value since 2017
• Figure 11: Most active animal health dealmakers 2017 to 2024